rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 15

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-00827 · 2003

Neuropeptide Systems: The Next Generation of Antidepressants and Anxiolytics

Multiple neuropeptide systems (CRF, NPY, substance P/NK1, galanin, vasopressin, nociceptin) offer novel antidepressant and anxiolytic targets with mechanisms fundamentally different from monoamine-based drugs.

Holmes, Andrew; Heilig, Markus; Rupniak, Nadia M J; Steckler, Thomas; Griebel, Guy · Review

RPEP-00828 · 2003

Could Blocking Ghrelin Be the Key to Treating Obesity?

Ghrelin's unique status as the only circulating appetite-promoting hormone, combined with evidence from knockout and antibody studies, makes it a rational anti-obesity drug target for reducing hunger and fat accumulation.

Horvath, Tamas L; Castañeda, Tamara; Tang-Christensen, Mads; Pagotto, Uberto; Tschöp, Matthias H · Review

RPEP-00832 · 2003

Opioid Peptides Control Sex Hormone Production in Ovarian Cells

Mu-opioid receptor agonists inhibited basal and LH-stimulated progesterone and androstenedione production in porcine theca cells in a dose-dependent manner, demonstrating direct opioid peptide control of ovarian steroidogenesis.

Kaminski, T; Siawrys, G; Bogacka, I; Okrasa, S; Przala, J · In Vitro

RPEP-00834 · 2003

Russian Study Claims Thymus and Pineal Peptides Cut Death Rates Up to 4-Fold in Elderly Patients

In a 6-8 year follow-up study of 266 elderly people, treatment with thymic peptide (Thymalin) and pineal peptide (Epithalamin) bioregulators for 2-3 years was associated with dramatic reductions in mortality: 2.0-2.1 times lower with Thymalin, 1.6-1.8 times lower with Epithalamin, and 2.5 times lower with the combination. The most striking result: patients treated with both peptides annually for 6 years showed a 4.1-fold decrease in mortality compared to controls. Treated patients also showed improved cardiovascular, endocrine, immune, and nervous system function, a 2.0-2.4 fold reduction in respiratory infections, and lower rates of ischemic heart disease, hypertension, osteoarthritis, and osteoporosis.

Khavinson, Vladimir Kh; Morozov, Vyacheslav G · Clinical Trial

RPEP-00836 · 2003

Endothelin-1 Levels in Heart Failure Track Disease Severity and Predict Outcomes

Plasma ET-1 correlated with NYHA class, exercise capacity, and BNP in CHF patients, and independently predicted adverse outcomes, providing complementary prognostic information to natriuretic peptides.

Kinugawa, Toru; Kato, Masahiko; Ogino, Kazuhide; Osaki, Shuichi; Igawa, Osamu; Hisatome, Ichiro; Shigemasa, Chiaki · Cross Sectional

RPEP-00838 · 2003

Selank Improves Learning and Memory Specifically in Low-Performing Rats

Selank selectively enhanced conditioned avoidance learning and memory in rats with initially low learning ability while minimally affecting normal learners, demonstrating deficit-correcting rather than general cognitive enhancement.

Kozlovskii, I I; Danchev, N D · Animal Study

RPEP-00840 · 2003

Opioid Peptides Directly Slow Cell Growth in the Developing Uterus

Opioid peptides directly inhibited uterine cell proliferation in a developmental stage-dependent manner: strongest in immature tissue, diminishing with maturation, with different receptor subtypes active at different stages.

Környei, J L; Vértes, Z; Kovács, K A; Göcze, P M; Vértes, M · In Vitro

RPEP-00841 · 2003

Macrocyclic Peptides That Block Cancer Signaling: Targeting the Grb2 SH2 Domain

A macrocyclic peptide incorporating beta-aminophosphotyrosyl mimetic achieved potent Grb2 SH2 domain binding through conformational restriction, demonstrating macrocyclic drug design for cancer signaling disruption.

Lee, Kyeong; Zhang, Manchao; Liu, Hongpeng; Yang, Dajun; Burke, Terrence R · In Vitro

RPEP-00843 · 2003

Inflammation Shuts Down the Gut's Own Healing Peptide TFF3 Through NF-κB

TNF-alpha inhibited TFF3 transcription through NF-κB activation in intestinal cells, creating a pathogenic feedback loop where inflammation simultaneously damages the gut AND suppresses its natural repair peptide.

Loncar, M B; Al-azzeh, E-d; Sommer, P S M; Marinovic, M; Schmehl, K; Kruschewski, M; Blin, N; Stohwasser, R; Gött, P; Kayademir, T · In Vitro

RPEP-00844 · 2003

Beta-Endorphin Controls the Pleasure of Eating, Not Just How Much You Eat

POMC-derived beta-endorphin selectively modulated the appetitive (wanting/seeking) phase of feeding behavior in a deprivation-state-dependent manner, separating opioid reward from hunger-driven consumption.

Low, Malcolm J; Hayward, Michael D; Appleyard, Suzanne M; Rubinstein, Marcelo · Animal Study

RPEP-00848 · 2003

Long-Term Oral GHRP-2 Increases Appetite and Weight in GH-Deficient Adults

Chronic oral GHRP-2 in GH-deficient adults produced persistent increases in appetite and body weight alongside GH/IGF-1 elevation, confirming sustained orexigenic effects of long-term GH secretagogue therapy.

Mericq, Verónica; Cassorla, Fernando; Bowers, Cyril Y; Avila, Alejandra; Gonen, Boas; Merriam, George R · Clinical Trial

RPEP-00849 · 2003

PT-141: A Melanocortin Peptide That Treats Sexual Dysfunction Through the Brain

PT-141 (bremelanotide) induced sexual arousal in both male and female animals through central MC3R/MC4R activation, representing a mechanistically novel approach to sexual dysfunction treatment through brain desire pathways rather than peripheral blood flow.

Molinoff, P B; Shadiack, A M; Earle, D; Diamond, L E; Quon, C Y · Animal Study

RPEP-00854 · 2003

GH Secretagogues Directly Affect Skeletal Muscle Electrical and Contractile Properties

GH secretagogues directly modulated skeletal muscle electrical excitability and contractile properties through a muscle-specific ghrelin-type receptor, independent of GH release — revealing direct muscle-targeting activity.

Pierno, Sabata; De Luca, Annamaria; Desaphy, Jean-François; Fraysse, Bodvael; Liantonio, Antonella; Didonna, Maria Paola; Lograno, Marcello; Cocchi, Daniela; Smith, Roy G; Camerino, Diana Conte · In Vitro

RPEP-00855 · 2003

Early Life Maternal Separation Permanently Changes Brain Opioid Peptide Levels

Both short and long maternal separation produced distinct, persistent alterations in brain opioid peptide levels (dynorphin, met-enkephalin) across reward and stress regions in adult rats, demonstrating lasting neurochemical consequences of early life experience.

Ploj, Karolina; Roman, Erika; Nylander, Ingrid · Animal Study

RPEP-00856 · 2003

Gut Bacteria Byproducts Boost Your Colon's Natural Antibiotic Peptide LL-37

In healthy human colon and ileum tissue, LL-37 expression was restricted to differentiated epithelial cells. In cell culture, butyrate, isobutyrate, propionate, and the histone deacetylase inhibitor trichostatin A all increased LL-37 expression in colon cells alongside cell differentiation. Flavone also induced LL-37 but without affecting differentiation, demonstrating that LL-37 can be upregulated independently. Critically, when the MEK-ERK signaling pathway was blocked, butyrate-induced LL-37 expression was abolished — even though cell differentiation was actually enhanced. Conversely, blocking the p38/MAP kinase pathway stopped cell differentiation without inhibiting LL-37 expression. This separation of signaling pathways means LL-37 production and cell maturation are independently controllable, opening the possibility of specifically boosting antimicrobial peptide production through targeted dietary or pharmacological interventions.

Schauber, J; Svanholm, C; Termén, S; Iffland, K; Menzel, T; Scheppach, W; Melcher, R; Agerberth, B; Lührs, H; Gudmundsson, G H ·

RPEP-00858 · 2003

BPC-157 Cream Overcomes Steroid-Impaired Wound Healing in Burned Mice

Topical BPC-157 cream reversed methylprednisolone-induced burn wound healing impairment in mice, restoring wound closure rates during concurrent steroid treatment.

Sikiric, P; Seiwerth, S; Mise, S; Staresinic, M; Bedekovic, V; Zarkovic, N; Borovic, S; Gjurasin, M; Boban-Blagaic, A; Batelja, L; Rucman, R; Anic, T · Animal Study

RPEP-00860 · 2003

BPC-157 Accelerates Achilles Tendon Healing and Directly Stimulates Tendon Cell Growth

BPC-157 accelerated transected Achilles tendon healing in rats (improved biomechanics and histology) and directly stimulated tendocyte proliferation in vitro, demonstrating both functional repair and cellular mechanism.

Staresinic, M; Sebecic, B; Patrlj, L; Jadrijevic, S; Suknaic, S; Perovic, D; Aralica, G; Zarkovic, N; Borovic, S; Srdjak, M; Hajdarevic, K; Kopljar, M; Batelja, L; Boban-Blagaic, A; Turcic, I; Anic, T; Seiwerth, S; Sikiric, P · Animal Study

RPEP-00862 · 2003

MK-677 Increases Non-22kDa GH Isoforms — Growth Hormone Isn't One-Size-Fits-All

MK-677 treatment increased the proportion of non-22kDa and 20kDa GH isoforms relative to total GH in obese subjects, demonstrating that GH secretagogues alter the GH isoform profile differently from exogenous GH replacement.

Svensson, J; Boguszewski, C L; Shibata, F; Carlsson, B; Carlsson, L M S; Bengtsson, B-A · Clinical Trial

RPEP-00864 · 2003

All Three Opioid Peptide Families Reduce Aggression in Mice — But Through Different Mechanisms

All three endogenous opioid peptide families (endorphins, enkephalins, dynorphins) inversely correlated with aggression across brain regions, with each acting through distinct receptor systems (mu, delta, kappa) and neural circuits.

Tordjman, Sylvie; Carlier, Michèle; Cohen, David; Cesselin, François; Bourgoin, Sylvie; Colas-Linhart, Nicole; Petiet, Anne; Perez-Diaz, Fernando; Hamon, Michel; Roubertoux, Pierre L · Animal Study

RPEP-00865 · 2003

Milk-Derived Beta-Casomorphin Triggers Protective Mucus Release in the Gut

Beta-casomorphin-7 and casein hydrolysate stimulated mucus release in rat jejunum through mu-opioid receptor activation, providing a direct mechanism for dairy-derived gut protection through opioid peptide signaling.

Trompette, Aurélien; Claustre, Jean; Caillon, Fabienne; Jourdan, Gérard; Chayvialle, Jean Alain; Plaisancié, Pascale · Animal Study

RPEP-00867 · 2003

Dynorphin B Activates Nuclear Opioid Receptors to Turn Stem Cells Into Heart Cells

Dynorphin B activated nuclear opioid receptors coupling to nuclear PKC activation, which induced cardiac transcription factors (GATA-4, Nkx-2.5) for cardiogenesis in embryonic stem cells — a novel nuclear signaling mechanism.

Ventura, Carlo; Zinellu, Elisabetta; Maninchedda, Emiliana; Maioli, Margherita · In Vitro

RPEP-00868 · 2003

Endorphin-Triggered PKC Signaling Drives Heart Cell Development in Embryonic Stem Cells

Opioid-primed cardiogenesis in GTR1 embryonic stem cells was mediated by PKC epsilon nuclear translocation, which activated GATA-4 and Nkx-2.5 cardiac transcription — mapping the complete opioid-to-cardiac differentiation signaling cascade.

Ventura, Carlo; Zinellu, Elisabetta; Maninchedda, Emiliana; Fadda, Marina; Maioli, Margherita · In Vitro

RPEP-00871 · 2003

Opioid Peptides Control Airway Mucus and Water Transport in the Lungs

Peripheral opioid receptor activation in airway mucosa increased net water absorption, affecting mucociliary transport — identifying an opioidergic regulation of tracheobronchial respiratory defense mechanisms.

Wang, Lian; Tiniakov, Ruslan L; Yeates, Donovan B · Animal Study

RPEP-00872 · 2003

BNP and ANP After Heart Bypass Surgery: BNP Predicts Post-Operative Complications

Serial postoperative BNP levels predicted clinical complications and recovery trajectory after CABG, with persistent elevation identifying high-risk patients, while ANP was less discriminating.

Watanabe, Masazumi; Egi, Koso; Hasegawa, Satoru; Tanaka, Hiroyuki; Ohshima, Hisanaga; Sakamoto, Tohru; Sunamori, Makoto · Cohort

RPEP-00873 · 2003

Ghrelin — The Hunger Hormone — Promotes Deep Sleep in Humans

Intravenous ghrelin administration increased slow-wave sleep (deep sleep) across the total night and enhanced delta-wave activity during the second half of the night. REM sleep was reduced during the second third of the night, while other sleep stages were unaffected. Ghrelin also stimulated multiple hormonal responses: growth hormone and prolactin levels were elevated throughout the night, and cortisol rose during the first half. Interestingly, the GH response was strongest after the first injection and weakest after the fourth, while cortisol showed the opposite pattern. Leptin levels were unaffected.

Weikel, J C; Wichniak, A; Ising, M; Brunner, H; Friess, E; Held, K; Mathias, S; Schmid, D A; Uhr, M; Steiger, A · Clinical Trial

RPEP-00880 · 2004

Thymosin Alpha-1 Plus Interferon Improves Hepatitis C Treatment in a Randomized Trial

Thymosin alpha-1 + interferon-alpha achieved 40% SVR versus 20% for interferon alone in naive chronic hepatitis C patients (n=22), demonstrating significant immune-mediated enhancement of antiviral efficacy.

Andreone, P; Gramenzi, A; Cursaro, C; Felline, F; Loggi, E; D'Errico, A; Spinosa, M; Lorenzini, S; Biselli, M; Bernardi, M · RCT

RPEP-00881 · 2004

Cyclic Peptides That Block Cancer Cell Division by Targeting CDK2 Recruitment

Cyclic peptides targeting CDK2's substrate recruitment site (not catalytic site) selectively induced tumor cell apoptosis through the E2F pathway, with crystal structures confirming the novel binding mechanism.

Andrews, Martin J I; McInnes, Campbell; Kontopidis, George; Innes, Lorraine; Cowan, Angela; Plater, Andy; Fischer, Peter M · In Vitro

RPEP-00882 · 2004

MK-677 for Hip Fracture Recovery: Increased IGF-1 and GH But Mixed Functional Results

MK-677 increased GH and IGF-1 in elderly hip fracture patients with functional improvement trends, but the primary endpoint of functional independence was not statistically significant in this pilot RCT.

Bach, Mark A; Rockwood, Kenneth; Zetterberg, Carl; Thamsborg, Gorm; Hébert, Réjean; Devogelaer, Jean-Pierre; Christiansen, Jens Sandahl; Rizzoli, René; Ochsner, J Lockwood; Beisaw, Norman; Gluck, Oscar; Yu, Leisure; Schwab, Thomas; Farrington, Jeanne; Taylor, Alice M; Ng, Jennifer; Fuh, Vivian · RCT